For example, high MYC gene expression was found to be more frequent in the TNBC subtype than in ER+ and HER2+ tumors, and it was strictly associated with genes regulating glucose metabolism in ER− but not in ER+ cases, suggesting a differential role of this key oncogene in driving glucose metabolism in different BC subtypes [99]. This evidence concerns the gene ESR1 and breast cancer.